Released on: January 7, 2008, 10:49 am

Press Release Author: GTCBIO

Industry: Pharmaceuticals

Press Release Summary:
MONROVIA, CA - Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at
Novartis and Margery B. Fischbein, Vice President of Business Development &
Strategic Planning at Human Genome Sciences will give a joint presentation at
GTCbio's 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March
5-7 2008 in Philadelphia, PA.


Press Release Body: FOR IMMEDIATE RELEASE


December 20, 2008

Joint Presentation from Novartis and Human Genome Sciences at GTCbio's 5th
Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)

MONROVIA, CA - Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at
Novartis and Margery B. Fischbein, Vice President of Business Development &
Strategic Planning at Human Genome Sciences will give a joint presentation at
GTCbio's 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March
5-7 2008 in Philadelphia, PA.

They will present on "The Novartis / Human Genome Sciences Albuferon Alliance - Key
Success Factors in Driving Successful Biotech / Big Pharma Alliances." Their
presentation highlights
. Motivations for Pharma-Biotech Collaborations
. Novartis and Human Genome Sciences Business Development Drivers
. Overview of Human Genome Sciences and Novartis Pipeline
. Our Shared Collaboration Philosophy and Deal Structure
. Alliance Challenges and Synergies
. Best Practices and Key Lessons Learned

The conference also features presentations from AstraZeneca, Baselia, Biota,
Boehringer Ingelheim, Eli Lilly and Company, Global Alliance for TB Drug
Development, GlaxoSmithKline, Merck, Wyeth and many more. The full agenda is
available online at www.gtcbio.com.

The 5th Anti-Infectives Partnering & Deal Making Summit is an infectious disease
partnering and business development conference that gives global biotechnology and
pharmaceutical companies an opportunity to network with high-level executives from
top pharma and various biotech/pharmaceutical companies, as well as explore
potential collaborations, and learn about relevant anti-infective issues and deals
that will affect the industry.

This event also provides a unique venue for attendees to learn about the
anti-infective business development trends, the infectious disease markets, and
novel technologies that shape up the industry. For more information, please visit
www.gtcbio.com.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com




Web Site: http://

Contact Details: Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
infogtcbio@gtcbio.com